Skip to main content

RCGHX

ETF
RCGHX · UNKNOWN · 25 holdings

Quick Summary

Price History

Concentration Risk

55.86% Top-heavy
Low risk High risk

The top 10 holdings make up 55.86% of this ETF. A bad day for those few names drags the whole fund down with them.

Top Holdings Today

Weighted by position size
LLY
▼ -0.11%
ABBV
▲ 0.27%
ISRG
▼ -2.19%
MCK
▲ 0.45%
VRTX
▼ -1.37%
IDXX
▼ -1.86%
WST
▲ 1.24%
MTD
▼ -1.90%
COO
▼ -1.29%
TMO
▼ -2.95%
Weighted avg. of top holdings ▼ -0.78%

Sector Allocation

Healthcare
94.54%
Services
1.87%

Top 10 Holdings

55.86% of fund
LLY Eli Lilly & Co
15.15%
ABBV AbbVie Inc
5.57%
ISRG Intuitive Surgical Inc
5.16%
MCK McKesson Corp
4.63%
VRTX Vertex Pharmaceuticals Inc
4.53%
IDXX IDEXX Laboratories Inc
4.52%
WST West Pharmaceutical Services I
4.23%
MTD Mettler-Toledo International I
4.07%
COO Cooper Cos Inc/The
4.06%
TMO Thermo Fisher Scientific Inc
3.94%
Other positions
3.59%

All Holdings (25)

Top 10: 55.86% of fund
# Ticker Name Weight Shares Market Value
1 LLY Eli Lilly & Co 15.15% 14,604 15.69 M
2 ABBV AbbVie Inc 5.57% 25,272 5.77 M
3 ISRG Intuitive Surgical Inc 5.16% 9,449 5.35 M
4 MCK McKesson Corp 4.63% 5,844 4.79 M
5 VRTX Vertex Pharmaceuticals Inc 4.53% 10,347 4.69 M
6 IDXX IDEXX Laboratories Inc 4.52% 6,931 4.69 M
7 WST West Pharmaceutical Services I 4.23% 15,932 4.38 M
8 MTD Mettler-Toledo International I 4.07% 3,022 4.21 M
9 COO Cooper Cos Inc/The 4.06% 51,335 4.21 M
10 TMO Thermo Fisher Scientific Inc 3.94% 7,048 4.08 M
Showing top 10 of 25 holdings · Listed: 96.41% · 3.59% in other positions

Precio Objetivo de Analistas

No hay cobertura de analistas disponible

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: N/A · Net Margin: N/A
Revenue (TTM) N/A Net Income (TTM) N/A
ROE N/A ROA N/A
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) N/A
ROIC N/A FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: N/A
Debt / Equity N/A Current Ratio N/A
Interest Coverage N/A Asset Turnover N/A
Working Capital N/A Tangible Book Value N/A

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: N/A · EV/EBITDA: N/A
P/E Ratio N/A Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield N/A
Market Cap N/A Enterprise Value N/A

Per Share

EPS: N/A · FCF/Share: N/A
EPS (Diluted TTM) N/A Revenue / Share N/A
FCF / Share N/A OCF / Share N/A
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: N/A · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion N/A
SBC-Adj. FCF N/A Growth Momentum N/A

Comparación con Pares

vs mediana del sector ETF (25157 pares)
Métrica Acción Mediana del Sector
P/E
P/B
ROE %
Net Margin %
Rev Growth 5Y %
D/E